![[Podcast] Behind the Breakthroughs: How Almac Powers Clinical Trial Success with Care](https://imgproxy.divecdn.com/5lAJkli_KcGt1FSsw4EaegjgP76IHREqYEWbhNBJOXw/g:ce/rs:fit:770:435/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9CaW9QaGFybWFEaXZlXzEzNDZfeF83MjlfQXJ0d29yay5qcGc=.webp)
.jpg)
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
“23andMe might have filed for bankruptcy, but the transformation it brought to h...
Harmony Biosciences has named Adam Zaeske its chief commercial officer, luring t...
Dr. Oz, a former heart surgeon and TV host, is closer to becoming CMS administra...
The company's Blujepa is the first in a new class of oral antibiotics for UTIs i...
NIH terminated grants for a program studying how to diagnose, treat, and prevent...
TUESDAY, March 25, 2025 -- There are racial and geographic disparities in the in...
TUESDAY, March 25, 2025 -- In a clinical guideline issued by the American Colleg...
TUESDAY, March 25, 2025 -- For patients with resected stage IB-IIIA epidermal gr...
TUESDAY, March 25, 2025 -- The Aquablation water-based surgical procedure is saf...
TUESDAY, March 25, 2025 -- For individuals with dominantly inherited Alzheimer d...
TUESDAY, March 25, 2025 -- In anterior cruciate ligament reconstruction (ACLR) a...
TUESDAY, March 25, 2025 -- Exclusive or longer duration of breastfeeding (at lea...
TUESDAY, March 25, 2025 -- From 2013 to 2022, the U.S. pedestrian and road traff...
President Trump has nominated a Republican attorney who was once accused of mish...
NIH terminated grants for a program studying how to diagnose, treat, and prevent...
The CDC was rocked by five high-level departures on Tuesday in the latest turmoi...
![Human medicines European public assessment report (EPAR): Zabdeno, ebola vaccine (Ad26.ZEBOV-GP [recombinant]), Date of authorisation: 01/07/2020, Revision: 8, Status: Authorised](https://www.ema.europa.eu/sites/default/files/styles/oe_bootstrap_theme_medium_no_crop/public/2024-07/EMA_building_202407_v1-copyright-EMA.png?itok=NBYia_Eu)
Human medicines European public assessment report (EPAR): Zabdeno, ebola vaccine...
Human medicines European public assessment report (EPAR): Amvuttra, vutrisiran, ...
Human medicines European public assessment report (EPAR): Abrysvo, Respiratory s...
Human medicines European public assessment report (EPAR): Comirnaty, COVID-19 mR...
Human medicines European public assessment report (EPAR): Emadine, emedastine, D...
Novo Nordisk said it's licensed a new obesity drug from The United Laboratories,...
Human medicines European public assessment report (EPAR): Ocrevus, ocrelizumab, ...
Human medicines European public assessment report (EPAR): Dupixent, dupilumab, D...